Dublin, July 31, 2023 (GLOBE NEWSWIRE) -- The "Thyroid Cancer Drugs Global Market Report 2023" has been added to ResearchAndMarkets.com's offering.
This report provides a comprehensive guide to the trends shaping the thyroid cancer drugs market over the next ten years and beyond, with valuable insights into market characteristics, growth, segmentation, regional breakdowns, competitive landscape, and more.
Global Thyroid Cancer Drugs Market to Witness Strong Growth
The global thyroid cancer drugs market is on a robust growth trajectory, projected to increase from $0.71 billion in 2022 to $0.81 billion in 2023, at an impressive compound annual growth rate (CAGR) of 14%. Over the forecast period, the market is expected to grow even further to $1.29 billion in 2027, at a CAGR of 12.5%. Key factors driving this growth include increasing incidences of thyroid cancer, especially in women, and the rising adoption of targeted therapies for treatment.
Insights into Thyroid Cancer Drugs and Regional Market Dynamics
The report covers various thyroid cancer drugs, including cabozantinib-s-malate, caprelsa, and cometriq. It provides 'factory gate' values, representing the value of goods sold by manufacturers to downstream entities or directly to end customers. The market covers different regions, such as Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, and Africa.
Understanding Thyroid Cancer Drugs and Their Impact
Thyroid cancer drugs are used to treat thyroid cancer by blocking kinase proteins. These medications prevent tumors from growing new blood vessels and target proteins produced by cancer cells to aid in their growth. The report explains how thyroid tissue made up of follicular cells and parafollicular cells can develop cancer.
Driving Factors and Challenges in the Market
The increasing incidences of thyroid cancer, particularly in women, are propelling market growth. For instance, the American Cancer Society estimated approximately 43,800 new cases of thyroid cancer in the United States in 2022, with 31,940 cases in women and 11,860 cases in men. However, the report also highlights challenges like the use of targeted therapies, which can act as a restraint on the thyroid cancer drugs market.
Thyroid Cancer Drugs Market Players and Forecast
The report includes a list of major players in the thyroid cancer drugs market, such as Mylan Pharmaceuticals Inc., Alara Pharmaceutical Corporation, Bristol Myers co., and more. It offers forecast data and trends shaping the market for supporting strategic decision-making, investment, and competitive benchmarking.
ReportScope
Markets Covered
- By Drug Type: Ipilimumab; Cabozantinib-S-Malate; Caprelsa (Vandetanib); Doxorubicin Hydrochloride; Lenvatinib Mesylate; Nivolumab; Vandetanib; Other Drug Types
- By End Users: Hospitals; Oncology Clinics; Research Organizations; Other End-Users
- By Type: Radioiodine Ablation; Thyroid Stimulating Hormone (THS) Suppression; Chemotherapy; Targeted Multikinase Therapy; Other Types
Key Attributes:
| Report Attribute | Details |
| No. of Pages | 175 |
| Forecast Period | 2023 - 2027 |
| Estimated Market Value (USD) in 2023 | $0.81 billion |
| Forecasted Market Value (USD) by 2027 | $1.29 billion |
| Compound Annual Growth Rate | 12.3% |
| Regions Covered | Global |
Company Coverage:
- Mylan Pharmaceuticals Inc.
- Alara Pharmaceutical Corporation
- Bristol Myers
- Teva parenteral medicines
- Jerome Stevens Pharmaceuticals
- Baxter International Inc.
- Abbott laboratories
- APP pharmaceuticals
- AstraZeneca PLC
- GlaxoSmithKline plc
- Exelixis
- Novartis AG
- Pfizer Inc.
- Biovista
- Vascular Biogenics
- Azaya Therapeutics
- Bionomics
- Bayer
- Eisai
- Bio-Path Holdings
- Takeda Pharmaceutical Company
For more information about this report visit https://www.researchandmarkets.com/r/kc5ldx
About ResearchAndMarkets.com
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
Attachment
